1. Introduction {#sec1}
===============

Lung alveolar pulmonary adenocarcinoma is one of the primary cause of lung cancer in related to high mortality not only in developing countries but also worldwide \[[@bib1], [@bib2]\]. In Indonesia, lung cancer is on the first position cause of death in cancer patients. The high prevalence of lung adenocarcinoma in Indonesia is mainly due to smoking habits and also industrial waste, such as fly ash, bottom ash, and coal ash \[[@bib3]\]. Recently, clinical therapies including surgery, chemotherapy, allopathy medicine and radiotherapies are successful as concurrent therapeutic approaches against lung cancer, however, several marked chances of undesirable and adverse side effects caused by such therapies need to be managed \[[@bib4]\]. Moreover, especially in developing countries, the therapeutic system is extremely expensive. Therefore, there is huge demand for alternative medicine in Indonesia.

The use of medicinal plants in chemoprevention is need to be consideration as an ideal treatment with good efficacy and few side effects compared with allopathic medicine \[[@bib5]\]. Recently, evidences have shown that the prescription of new treatment methods that are derived from plants or herbal medicine could reduce cancer mortalities until 25%, thus it proves that plants or herbal medicine plays an important role in curing cancer symptoms and treatments \[[@bib6], [@bib7]\]. The use of herbal remedies as complementary and alternative medicines (CAMs) has also been widely used on United Kingdom (UK) and the rest of Europe such as France and Germany, as well as in North America and Australia \[[@bib8]\]. In addition, dietary intake of phytochemicals as a chemoprevention agents may reduce the risk of cancer, detoxification of highly reactive molecules and has antitumor potential against lung cancer \[[@bib9]\].

Basically, chemoprevention agents are compounds that prevent development of cancer \[[@bib10]\]. Their preventive effects are attributed to intervening in interaction of the carcinogen with cellular DNA, altering intracellular signaling pathways as results of stopping progression of an initiated cell through pre-neoplastic changes into a malignant cell, inhibiting angiogenesis, inducing cell cycle arrest, and triggering apoptosis \[[@bib11], [@bib12], [@bib13]\]. It is believed that the apoptosis induced by chemoprevention agents may not only inhibit the carcinogenesis induced by carcinogens, but also may suppress the growth of tumor and enhance the cytotoxic effects of antitumor drug on tumor, which plays an important role in the antitumor therapies \[[@bib14]\].

The genus *Ocimum*, belonging to the family Labiatae or Laminaceae, is widely found in tropical and subtropical countries \[[@bib15]\]. In Indonesia, *Ocimum sanctum* is very easy to find and use commonly as vegetable food. It is well-known that *Ocimum sanctum* acts as a chemopreventive, anti-carcinogenic, free radical scavenger and also used as a medication for neurodegenerative diseases \[[@bib15], [@bib16], [@bib17], [@bib18]\].

In recent years, there is a tremendous research work going on OS to understand its additional pharmacological properties. For instance ethanolic extract of *Ocimum sanctum* induced apoptosis of lewis lung carcinoma \[[@bib19]\], and aqueous extract of *Ocimum gratissimum* avoided the breast cancer proliferation through inhibition of matrix metalloproteases \[[@bib20]\]. Further, *Ocimum sanctum essential oil* demonstrated in promoting cytotoxic and apoptotic activity in human colorectal adenocarcinoma cells \[[@bib21]\]. It has been used in a variety of forms for consumption, the aqueous leaf extract and seed oil are reported to show chemopreventive and antiproliferative activity in Hela cells \[[@bib22]\]. Ethanolic extract of *Ocimum sanctum* (EEOS) leaf also has been shown to have a significant influence on carcinogen metabolizing enzymes including cytochrome P450, cytochrome b5, and aryl hydrocarbon hydroxylase \[[@bib23], [@bib24]\]. Additionally, *Ocimum sanctum* prepared in the form of fresh leaf paste, aqueous, and ethanolic extract has been reported to reduce the incidence of papillomas and squamous cell carcinoma in carcinogen-treated hamsters \[[@bib25]\]. Nevertheless, how the mechanisms of ethanolic extract of *Ocimum sanctum* (EEOS) underlying anticancer property remains unclear. Therefore, in the present study, the anticancer effects of EEOS were investigated using human lung carcinoma A549 cells.

2. Materials and methods {#sec2}
========================

2.1. Preparation of *Ocimum sanctum linn.* ethanolic extract {#sec2.1}
------------------------------------------------------------

*O. sanctum* leafs were derived from Center for Research and Development of Medicinal Plants and Traditional Medicines, Ministry of Health in Tawangmangu, Central Java, Indonesia. Crude extracts and ethanolic extracts of *O. sanctum* were prepared as previously described \[[@bib15]\]. Then, the ethanolic extracts were diluted with phosphate buffer saline (PBS) pH 7,4 to prepare there different concentrations (50 μg/ml, 70 μg/ml, 100 μg/ml) (Gibco, Waltham, MA, USA).

2.2. Cell culture of A549 cells {#sec2.2}
-------------------------------

Lung adenocarcinoma cell A549 were maintained and cultured in DMEM supplemented with FBS containing 100 g/ml penicillin/streptomycin at 37 °C in a humidified atmosphere. Cells were seeded in T-75 culture flask and grown to approximately confluence. EEOS treatments were performed by incubating cells with several concentrations (50, 70, 100 ug/ml) of EEOS (w/v) in serum-free DMEM for 24 h. After the EEOS treatments, the cells were washed with PBS pH 7,4 and collected for following analyses.

2.3. Cell viability assay {#sec2.3}
-------------------------

Cell viability was determined by MTT assay as previously describe \[[@bib17]\] in the absence or presence of 50, 70, 100 or 200 ug/ml  EEOS. After 48 h treatments, culture medium was aspirated and cells were incubated with MTT (0,5 mg/ml) at 37 °C for 4 h. The viable cell number was directly proportional to the production of formazan, which was dissolved in isopropanol and determined by measuring the absorbance at 570 nm using a microplate reader (SpectraMAX 360 pc, Molecular Devices, Sunnyvale, CA).

2.4. Adhesion assay {#sec2.4}
-------------------

The adhesion assay are performed like previously describe \[[@bib26], [@bib27], [@bib28]\]. Microtiter wells (Greiner Bio-one, Frickenhausen, Germany) were coated with vitronectin (Athens Research and Technology, Athens, GA, USA) or BSA (Serva, Heidelberg, Germany) in HBS buffer (119 mM NaCl, 4 mM KCl, 11 mM Glucose in 20 mM Hepes buffer) overnight at 4 °C. After washings, wells were then blocked with 100 μl 3% BSA for 1 h at 4 °C. Aliquots of washed A549 cells (1-4 x10^6^) were added together with EEOS (final concentration 50 μg/ml, 70 μg/ml, and 100 μg/ml) for 1 h at 37 °C. cRGD was run as positive control detachment. Wells were washed once, and adherent cells were stained with crystal violet (Sigma, Steinheim, Germany) and measured in a microtiter reader at 592 nm (Sunrise™, Tecan, Männedorf, Germany).

2.5. Apoptosis assay {#sec2.5}
--------------------

The apoptosis assay are performed like previously describe \[[@bib26], [@bib27], [@bib28]\]. Cell apoptosis was measured by the Caspase-Glo 3/7 assay (Promega, Madison, WI, USA). 100 μl vitronectin (2 μg/mL; Athens Research & Technology, Athens, GA, USA) were coated on 96 white well plates (Corning Incorporated, Corning, NY, USA) for 8 h. Aliquots of 450 μl A549 suspensions (1-2x10^6^ cells in DMEM medium) were incubated with EEOS (final concentration 100 μg/ml), and cRGD (final concentration 20 μg/ml), then seeded onto vitronectin coated wells for 16 h at 37 °C, 5% CO~2~. 100 μl of Caspase-Glo 3/7 reagents were then added at room temperature and luminescence was measured using a microtiter reader (FLX800, Biotek Instrument Winooski, VT, USA).

2.6. DAPI staining {#sec2.6}
------------------

DAPI staining was performed to assess morphological changes in the chromatin structure of A549 cells undergoing apoptosis as previously described \[[@bib28]\]. Aliquots of 10^5^ A549 were seeded onto μ-slide well (Ibidi, Martinsried, Germany) precoated with vitronectin (see above) together with purified human IgG (final concentration 20 μg/ml), mab (final concentration 20 μg/ml) and or cRGD (final concentration 20 μg/ml) for 16 h at 37 °C, 5% CO~2.~ After washings with 300 μl ice-cold PBS pH 7.4 (PAN, Aidenbach, Germany), cells were fixed with 300 μl 4% paraformaldehyde (PFA; Sigma) for 15 min and incubated with 1 μg/ml blue fluorescing dye (Hoechst 33342; Thermo Scientific, Rockford, IL, USA) for 3 min at RT. Stained chromatin DNA condensation and fragmentation was analysed using confocal microscopy with 60x magnification (Nikon Eclipse TE2000-E, Tokyo, Japan).

2.7. Acridine Orange/Ethidium Bromide staining (AO/EB) {#sec2.7}
------------------------------------------------------

A549 cells (1 × 10^5^) were seeded in 24 well plate. Cells were incubated in CO~2~ incubator with 37 °C temperature and 5% CO~2~ then treated with 100 μg/ml (final concentration) of EEOS re-incubate for 24 h. Cells were fixed with 1 ml of 4% parafomaldehyde for 15--20 min in room temperature. Cells were washed with PBS 1x for three times. Cells were stained with Hoechst 10 μg/ml and *Acridine Orange/Ethidium Bromide* (AO/EB) 10 μg/ml on each well and then incubated for 15 min in humid chamber with 37 °C temperature. Cells were washed with PBS 1x then the cells were ready to be visualised by fluorescence inverted microscope.

2.8. Reactive oxygen species (ROS) analysis {#sec2.8}
-------------------------------------------

80% of confluent A549 cells in T75 flask were harvested with 3 ml Trypsin-EDTA 0.25% then incubated for 3 min in the incubator at 37 °C temperature with 5% CO~2~. After the cells were detached from the flask, growth medium was added to stop the trypsin. Cells suspension then transferred into 15 ml centrifuge tube and centrifuge on 1600 rpm for 5 min. The supernatant was aspirated and the cells pellet were mixed in 5 ml growth medium. Cells were counted and 2.5 × 10^5^ cells/0.5 ml transferred into FACS round tube. The cells were centrifuged on 1600 rpm for 5 min. The supernatant was aspirated, the cell pellet was resuspended using DCFDA 1x buffer +10% FBS. DCFDA 20 μM was added into cells suspension, then incubated for 45 min in the dark room maintaing 37 °C temperature and 5% CO~2~. After incubation, cells were treated with terbutyl hydroperoxide (TBHP) 250 μM (positive control), DCFDA 20 μM (negative control), DMSO 10%, and *Ocimum sanctum* extract 100 μg/ml for 4 h. ROS levels were measured using flow cytometer.

2.9. ELISA for caspase 9, caspase 3 and Bcl-2 {#sec2.9}
---------------------------------------------

The activity level of caspase 9, caspase 3, and Bcl-2 measured by colorimetric assay kit (Abcam, Cambridge, MA, USA) according to the manufacturer\'s protocol. Briefly, the cells were collected and resuspended in lysis buffer containing 50 mmol/L Hepes, pH 7.4, 0.1% CHAPS, 1 mmol/L DTT, 0.1 mmol/L EDTA and 0.1% Triton X-100. Following incubation for 30 min on ice, cell lysate was centrifuged at 11000 g for 10 min at 4 °C, and the protein concentration in the supernatants was measured using the Bradford method. The supernatants were incubated with reaction buffer containing 2 mmol/L Ac-DEVD-AFC for caspase-3 and LEHD-AFC for caspase-9 (Abcam, Cambridge, MA, USA) in a caspase assay buffer at 37 °C with 10 mmol/L DTT for 30 min. Caspase activity was determined by measuring the absorbance at 405 nm (Infinite Pro 200, Tecan, Mannedorf, Switzerland). terbutyl hydroperoxide (TBHP) 250 μM was run as positive control. In the same way, 50 μL of the sample were put on the 96 well, followed by adding 50 μL of the Bcl-2 antibody cocktail to each well. Incubate for 1 h at room temperature on a plate shaker set to 400 rpm. Wash each well for three times, after the last wash add 100 μL of TMB Substrate, incubate for 10 min. After last incubation put 100 μL of stop solution to each well. The expression of Bcl-2 was record on the OD at 450 nm. In all experiment, to correct the nonspecific binding, backgrounds (negative control) were run for cell lysate sample in parallel without the sampel. Cutoff values were determined as the mean signal of negative control (n = 10) plus three standard deviations (SDs).

2.10. FOX assay {#sec2.10}
---------------

FOX reagent were composed of 100 uM xylenol orange (Merck, Darmstadt, Germany), 250 uM ammonium ferrous sulfate (Sinopharm Chemical Reagent, Shanghai, China), 90% methanol (Merck, Darmstadt, Germany), 4 mM BHT (Acros Organics, New Jersey, USA) and 25 mM H~2~SO~4~ (Merck, Darmstadt, Germany) Halliwell and Whiteman (2004) and Rhee (2010) \[[@bib29],[@bib30]\]. 50 ul sample were added to 550 ul FOX reagent. The samples were incubate at room temperature for 30 min then read immediately at 460 nm.

2.11. ELISA superoxide dismutase (SOD2) {#sec2.11}
---------------------------------------

The assay is conducted using ELISA Superoxide Dismutase (SOD 2) kit (Fine Test, Wuhan, China). The plate were washed 2 times before adding standard, sample, and control (zero) wells. 100 ul standard or sample was added to each well and incubate for 90 min at 37 °C. Aspirate and wash the plates 2 times. 100 ul Biotin-labeled SOD 2 antibody working solution was added to each well and incubated for 60 min at 37 °C. Aspirate and wash the plates 3 times. 100 ul SABC working solution was added to each well and incubated for 30 min at 37 °C. Aspirate and wash the plates 5 times. 90 ul TMB substrate was added and incubated 15--30 min at 37 °C. 50 ul stop solution was added, and read the plate at 450 nm immediately.

2.12. ELISA glutathione peroxidase (GPx) {#sec2.12}
----------------------------------------

The assay is conducted using ELISA Glutathione Peroxidase 1 (GPX1) kit (Fine Test, Wuhan, China). The plate were washed 2 times before adding standard, sample, and control (zero) wells. 100 ul standard or sample was added to each well and incubate for 90 min at 37 °C. Aspirate and wash the plates 2 times. 100 ul Biotin-labeled GPX1 antibody working solution was added to each well and incubated for 60 min at 37 °C. Aspirate and wash the plates 3 times. 100 ul SABC working solution was added to each well and incubated for 30 min at 37 °C. Aspirate and wash the plates 5 times. 90 ul TMB substrate was added and incubated 15--30 min at 37 °C. 50 ul stop solution was added, and read the plate at 450 nm immediately.

2.13. Qualitative assay of phenolic and flavonoid by Thin Layer Chromatography {#sec2.13}
------------------------------------------------------------------------------

The qualitative assay of phenolic was determined by putting 50 mg sample into test tube and extracted by using vortex for 3 min and 1 ml ethanol as solvent. Ethanol phase was aspirated then 20 ul sample was spotted on silica gel plate (Merck, Darmstadt, Germany) including gallic acid (Sigma Aldrich, St. Louis, USA) as comparation. The plate was put on saturated chamber (CAMAG, Muttenz, Switzerland) with mobile phase, the mix solution of 9.5 ml methanol (Merck, Darmstadt, Germany) and 0.5 ml formic acid 10% (Merck, Darmstadt, Germany), then elute until the border. The plate was dry off, observed under UV light (Sankyo Denki, Kanagawa, Japan), and spray using ferri chloride reagent (Merck, Darmstadt, Germany). Subsequently, the same methode was run for the flavonoid, with the modification of the comparation (quercetin) and the mobile phase, the mix solution of 6.0 ml n-hexane (Merck, Darmstadt, Germany), 4.0 ml ethyl acetate (Merck, Darmstadt, Germany), and 0.1 ml formic acid (Merck, Darmstadt, Germany).

2.14. Quantitative estimation of polyphenols {#sec2.14}
--------------------------------------------

The total phenolic contents were determined using Folin-Ciocalteu reagent (FCR) (Merck, Darmstadt, Germany) where as gallic acid (Sigma Aldrich, St. Louis, USA) was used as a standard antioxidant. 50 mg sample were added to 0,5 ml FCR and diluted in 7,5 ml aquabidest, followed by 10 min incubation in room temperature. 1,5 ml Na~2~CO~3~ 20% were added, then diluted with aquabidest until 10 ml. The solution were diluted 25 times and transferred to the cuvette, the absorbance were read at 760 nm using spectrophotometer (Shimadzu, Nagoya, Japan). Total phenolic was expressed in % gallic acid equivalent/gram extract (% b/b).

2.15. Quantitative estimation of flavonoids {#sec2.15}
-------------------------------------------

The flavonoid content was determined using quercetin (Sigma Aldrich, St. Louis, USA) as a standard antioxidant. 0,3 ml 5% natrium nitrite was added to 0,05 g sample. After 5 min. 0,6 ml aluminium chloride 10% were added and incubate for 5 min followed by 2 ml NaOH 1M addition and aquadest until 10 ml with volumetric flask. The solution was diluted 50 times and transferred into cuvette. The absorbance was recorded in spectrophotometer (Shimadzu, Nagoya, Japan) at 510 nm. The total flavonoid content was expressed in % quercetin equivalent/gram extract (% b/b).$$Total\ Fenol\ or\ Flavonoid\ \left( \% b/b \right) = \ \frac{Absorbance\ \left( {ppm} \right)x\ End\ Volume\ \left( {ml} \right)}{Sampel\ weight\ \left( g \right)}/10000$$

3. Results {#sec3}
==========

To address the beneficial use and the role of EEOS in the lung adenocarcinoma, we investigated in the *in vitro* A549 cell culture model system by the treatment of A549 cells with different concentrations of OS. Cells adhesion to the extracellular matrix is a crucial part to guarantee the cells growth, survival, and communication. To analyze the ability of EEOS-inducing A 549 cells detachment we performed adhesion assay.

3.1. EEOS induces detachment of A549 cells into extracellular matrix {#sec3.1}
--------------------------------------------------------------------

A549 cells (3 × 10^5^ cells/ml) were cultured on vitronectin coated culture dishes and treated for 18 h with different concentrations of EEOS (50 ug/ml, 70 ug/ml, 100 ug/ml). cRGD peptide (20 ug/ml) treated A549 cells were used as a control. These cultures were subjected to adhesion assay and interestingly, EEOS induces cell detachment in a dose dependent manner in A549 cells. The optimal concentrations of EEOS with a dose of 100 ug/ml showed enormous cell detachment in comparison to the other concentrations. All of our experimental groups that were treated with EEOS (50 ug/ml, 70 ug/ml, 100 ug/ml) inhibited the binding of A549 onto immobilized vitronectin ([Fig. 1](#fig1){ref-type="fig"}A). Interestingly, the higher concentration of EEOS 200 ug/ml reduced the ability to inhibit gel attachment in comparison to the lower concentration of 70 ug/ml.Fig. 1EEOS induced detachment of A549 into extracellular matrix (A) and decreased the viability of A549 cells significantly (B). Adhesion assay (A) performed by added the cells in the microtiter wells pre-coated with vitronectin. After washing, adherent cells were stained with crystal violet and measured in an ELISA reader. MTT assay (B) performed by incubating the cells in the presence of 50, 70, 100 or 200 ug/ml  EEOS. After 48 h treatments, the cells were incubated with MTT 5 mg/ml for 4 h) at 37 °C. The viable cell number determined by measuring the absorbance at 570 nm using a microplate reader. Statistical analysis was performed by one-way ANOVA followed by Bonferroni\'s post-hoc test; n.s. = not significant. cRGD was used as a positive control anoikis.Fig. 1

3.2. EEOS decreases significantly the viability of A549 cells {#sec3.2}
-------------------------------------------------------------

In addition to adhesion assay, using this model we also performed the viability assay. Similarly, the cells were treated with EEOS (50--200 μg/mL) and the cell viability was assessed by the MTT. EEOS significantly exhibited cytotoxic effect in human A549 cells, demonstrated with %-mean viability decrement in a concentration dependent manner ([Fig. 1](#fig1){ref-type="fig"}B) compared with the untreated control. In addition, EEOS at 100 μg/mL induced most severe cytotoxicity in A549 cells, which was almost comparable to its positive control cRGD, while non-treated cells did not show any significant cytotoxicity as a negative control. Interestingly, the treatment of A549 cells with 200 μg/mL EEOS demonstrate less but still still exhibiting significant cytotoxic effect in A549 cancer cells.

3.3. EEOS treatment induced apoptosis and promote ROS production in A549 cells {#sec3.3}
------------------------------------------------------------------------------

To demonstrate the anticancer effect of EEOS in A549 cels, we performed an apoptosis assay by using caspase-Glo 3/7. Indeed, this experiment showed that the EEOS treatment induced apoptosis in A549 cells in comparison to the untreated cells. Further, the cRGD used as a positive control ([Fig. 2](#fig2){ref-type="fig"}A and B). Since the concentration of EEOS 200 ug/ml did not show the results with adhesion and viability assay, therefore, this concentration was not included in this experiment. In addition, DNA fragmentation analysis by DAPI staining also showed significant cell shrinkage and DNA fragmentation in the 100 ug/ml EEOS treated cells in comparison to the control cells ([Fig. 2](#fig2){ref-type="fig"}B). Those findings are further confirmed by Hoechst 33342 and acridine orang/ethidium bromide (AO/EB) staining ([Fig. 2](#fig2){ref-type="fig"}C). It\'s found that only less cells exhibit blue fluorescence of Hoechst 33342 on EEOS treatment which means the apoptosis rate of EEOS treatment group is higher than control group. Acridine orange/ethidium bromide staining also can be seen qualitatively that AO/EB control cells exhibit green colours. Green colour cells represents normal, viable and non-apoptotic cells. On the other hand, EEOS treatment group exhibit orange fluorescent that represent apoptotic cells. It is known that disruption of cell adhesion into extracellular matrix results in detachment-induced apoptosis, termed anoikis, which is associated with increased intracellular ROS level.Fig. 2EEOS induced apoptosis in A549 cells. (A) Caspase-Glo 3/7 assay was performed by coated the vitronectin on 96 well plate for 8 h, then aliquots of A549 suspensions were incubated with EEOS and cRGD then seeded into vitronection coated wells for 16 h. 10 μl of Caspase-Glo 3/7 reagents were then added and luminescence was measured using a microtiter reader. (B) DAPI staining of A549 (NT, cRGD and 100 ug/ml EEOS) were performed using confocal microscopy with 60x magnification. (C) Acridine Orange-Ethidium Bromide (AO/EB) Staining. 10^5^ A549 cells were seeded in 24-well plate. Cells were treated with 100 μg/ml (final concentration) of EEOS then incubate for 24 h, fixed with 1 ml of 4% parafomaldehyde for 15--20 min in RT. Cells were washed by PBS 1x, stained with Hoechst and AO/EB (10 μg/ml), incubated for 15 min. Cells were visualised by fluorescence inverted microscope. Green fluorescent represents viable cells, meanwhile orange fluorescent represents apoptotic cells.Fig. 2

To analyze whether EEOS can also trigger A549 anoikis, the generation of intracellular ROS induced by EEOS was measured by oxidation of DCFDA using flow cytometry. As shown in [Fig. 3](#fig3){ref-type="fig"}, ROS production was increased in a dose-dependent manner and optimum was at 100 ug/ml in EEOS treated cells as well as in the control group treated with trybutil hydroperoxide (TBHP). To exclude the involvement of cell culture medium components interactions with EEOS in inducing the cytotoxic effect, we performed the Fox Assay. Our results showed clearly that, there was no difference or very low effect in the hydrogen peroxide concentrations in the both medium non treated and treatment (NT vs EEOS 50 μg/mL vs EEOS 70 μg/mL vs EEOS 100 μg/mL vs 200 μg/mL: 0.1513 vs 0.1510 vs 0.1222 vs 0.1092 vs 0.1321) ([Fig. 4](#fig4){ref-type="fig"}).Fig. 3EEOS promoted ROS production in A549 cells. 80% confluency of A549 in T75 flask were harvested with trypsin-EDTA 0,25%. Cells were counted and 2.5 × 10^5^ cells/0.5 ml transferred into FACS round tube. The cells were centrifuged on 1600 rpm for 5 min. The supernatant was aspirated and the pellet was resuspended using DCFDA 1x buffer +10% FBS. After incubation, cells were treated as follows. Cell only, TBHP 250 μM (positive control), DCFDA 20 μM (negative control), DMSO 10%, *Ocimum sanctum* extract 100 μg/ml. Cells were incubated for 4 h on 37 °C temperature and 5% CO~2~. ROS levels were measured using flow cytometer.Fig. 3Fig. 4EEOS treatment promoted oxidative stress in A549 cells. FOX assay was performed to answer that the cytotoxicity induced by EEOS is due to ROS generation. The cells were collected and resuspended in lysis buffer. 50 ul cell lysate were added to 550 ul FOX reagent. The samples were incubate at room temperature for 30 min then read immediately at 460 nm.Fig. 4

3.4. EEOS regulated apoptosis correlation to proteins in A549 cells {#sec3.4}
-------------------------------------------------------------------

Since increased ROS levels can disrupt the mitochondrial membrane potential thereby activating the apoptosis signaling pathway by involving the differential activity of different enzymes namely caspases. Therefore, in this study, pro-apoptotic and anti-apoptotic activities were analyzed in EEOS treated A549 cells. Interestingly, EEOS-treatment derived ROS might disrupt the mitochondrial membrane potential and activated caspase 9 and caspase 3 as shown in Figs. [5](#fig5){ref-type="fig"}A and B. This increased activity might promote the cleaved caspase-mediated PARP cleavage in A549 cells. In addition, EEOS-treatment in A549 cells decreased the activity of anti-apoptotic protein Bcl-2 in a concentration dependent manner ([Fig. 5](#fig5){ref-type="fig"}C). These data imply that EEOS treatment in A549 cells increases the ratio of Bax protein suggesting the activation of apoptotic pathway than survival or anti-apoptotic signaling mechanism ([Fig. 5](#fig5){ref-type="fig"}). These data suggest that EEOS induces apoptosis via activation of caspases and inhibition of anti-apoptotic protein in A549 cells.Fig. 5EEOS regulated apoptosis correlation to proteins in A549 cells. (A) Caspase 9 (B) Caspase 3 and (C) Bcl-2. The activity level of Caspase 9, Caspase 3, and Bcl-2 measured by colorimetric assay kit. The cells were collected and resuspended in lysis buffer. The cell lysate was centrifuged at 11000 g for 10 min at 4 °C, and the protein concentration in the supernatants was measured using the Bradford method. The supernatants were incubated with reaction buffer containing 2 mmol/L Ac-DEVD-AFC for caspase-3 and LEHD-AFC for caspase-9 (Abcam) in a caspase assay buffer at 37 °C with 10 mmol/L DTT for 30 min. Caspase activity was determined by measuring the absorbance at 405 nm. Statistical analysis was performed by one-way ANOVA followed by Bonferroni\'s post-hoc test; n.s. = not significant.Fig. 5

3.5. Oxidative stress induce by EEOS decrease the activity of antioxidant enzyme {#sec3.5}
--------------------------------------------------------------------------------

The main antioxidant defense enzymes that contribute in reducing the oxidative stress are superoxide dismutase (SOD) and glutathione peroxidase (GPx). Since the EEOS induced apoptosis and promote ROS production in A549 cells, we performed an ELISA assay to describe the activity of SOD and GPx. Our results demonstrated that, SOD2 activity was gradually decreased, however at the concentration of 200 μg/mL there was slightly increased level was detected ([Fig. 6](#fig6){ref-type="fig"}A). In addition, we observed a gradual decrease of GPx-activity during the treatment of cancer cells during increased EEOS concentration (from 50 ug/ml to 100 ug/ml) ([Fig. 6](#fig6){ref-type="fig"}B).Fig. 6EEOS suppressed antioxidant enzyme activity, (A) SOD and (B) GPx. Enzyme-linked immunosorbent assay was performed to describe SOD and GPX activity. The cells were collected and resuspended in lysis buffer. The cell lysate were tested using SOD and GPx ELISA kit. SOD and GPx activity were determined by measuring the absorbance at 450 nm.Fig. 6

3.6. The EEOS contain abundant polyphenol and flavonoid {#sec3.6}
-------------------------------------------------------

The experimental analysis on the TLC found that on the EEOS contain abundant polyphenol (12.50 % b/b) and flavonoid (28.22%b/b) ([Fig. 7](#fig7){ref-type="fig"}).Fig. 7The ingredient of EEOS based on Thin Layer Chromatography. (A) Flavonoid (Rf: 0,54; 0,84; 0,98) and (B) phenolic compound (Rf: 0,85) are positively contained in EEOS. The qualitative assay of phenolic was determined by putting 50 mg sample into test tube and extracted by using vortex and ethanol as solvent. Ethanol phase was aspirated then sample was spotted on silica gel plate including gallic acid as standard. The plate was put on saturated chamber with mobile phase then elute until the border. The plate was dry off, observed under UV light and spray using ferri chloride reagent. Subsequently, the same methode was run for the flavonoid with quercetin as standard.Fig. 7

4. Discussion {#sec4}
=============

Recently, several species of genus *Ocimum* are already in use as a herbal medicine not only in Asia but also in Europe and North America \[[@bib31]\]. Some evidences indicate that *Ocimum* extracts possess antitumor effects \[[@bib11], [@bib12], [@bib13], [@bib14]\]. Moreover, *Ocimum sanctum* combining with *Azadirachta indica* was reported to have a synergistic chemopreventive effects on chemical-induced gastric carcinogenesis \[[@bib32]\]. These studies illustrate the importance of OS as an anti-oxidant, anti-angiogenic, and anti-proliferative. Over the years, the herbal usage has been increased many folds and the conventional medical usage also showed the positive results \[[@bib8]\]. Therefore, we hypothesized that EEOS might exhibit beneficial effects in lung adenocarcinoma. However, there is no information about the mechanisms of the anticancer effect from ethanolic extract *Ocimum sanctum* (EEOS) in lung adenocarcinoma cells. In the present study, we investigated to understand the anticancer effects of EEOS in A549 cell culture model system.

We showed that the EEOS derived from the leaf of *Ocimum sanctum* is dose dependent (100 ug/ml). Based on our experiments, the adhesion and viability assays revealed that EEOS promoted cell detachment and decreased the cell viability at 100 ug/ml ([Fig. 1](#fig1){ref-type="fig"}A and B). It has been documented that cell adhesion to extracellular matrix (ECM) is essential for cell proliferation and survival \[[@bib33]\]. Inhibition of cell adhesion that disrupt the ligation between αvβ3 on the cell surface and vitronectin lead to cell anoikis \[[@bib34]\] and subsequently to cell apoptosis \[[@bib35], [@bib36], [@bib37], [@bib38]\]. In this experiments, we use Cyclic synthetic peptides containing the arginine-glycine-aspartate motif (cRGD) as a positive control to promote cell detachment and cell death. The cRGD targeted for integrin αvβ3, integrin αvβ3 plays a significant role in tumor angiogenesis and is a receptor for the extracellular matrix proteins with the expose of RGD tripeptide sequence. The αvβ3 integrin expressed on the tumoral endothelial cells as well as on the tumor cells \[[@bib39], [@bib40]\]. It has been shown the cRGD able to inhibit adhesion of various cells to several extracellular matrix proteins including fibronectin, vitronectin, von Willbrand factor, fibrinogen, thrombospondin and osteopontin. cRGD will strongly block cell attachment to the extracellular matrix and lead to cell death \[[@bib26], [@bib41]\]. Kim and colleagues also reported the inhibitory effect of ethanol leaf extract of *O. sanctum* extract on lung metastasis using the mouse LLC cells. Ethanol leaf extract of *O. sanctum* extract prevented cell adhesion and invasion of LLC cells to extracellular matrix (ECM) \[[@bib42]\].

Furthermore, to analyze its role in apoptosis, we performed an apoptotic assay. Interestingly, we found that the EEOS induced apoptosis in A549 cells ([Fig. 2](#fig2){ref-type="fig"}), in agreement to the results, our ROS analysis in the presence of EEOS also showed a significant increase in ROS ([Fig. 3](#fig3){ref-type="fig"}). In line with these results, cell detachment is normally associated with the activation of mitochondria to produce reactive oxygen species (ROS). It is well known that ROS can initiate and regulate the transcription and activation of different mediators which culminate in the common mechanism of cell damage via apoptosis caspase pathway \[[@bib43]\]. In addition, ROS is known to cause oxidative modification of DNA, proteins, lipids and cellular small molecules \[[@bib44]\]. Increased ROS levels are thought to constitute an essential step in apoptotic induction. Apoptosis or programmed cell death has two well known pathways, extrinsic and intrinsic pathways. In the case of the intrinsic pathway, a release of cytochrome C from mitochondria results in binding to Apaf-1 and subsequently leads to activation of procaspase-9 and following caspase-3. Activated caspase-3 exerts as the key executioner of apoptosis to induce the cleavage and inactivation of key cellular protein \[[@bib43], [@bib45]\]. In the present study, EEOS treatment demonstrated the increasing of caspase-3 expression level ([Fig. 5](#fig5){ref-type="fig"}), meanwhile this substance depressed the activity of anti-apoptotic protein Bcl-2. There is an evidence that early event in apoptosis is occur by the disruption of the mitochondrial membrane potential.

Apoptosis also contributes to morphological changes of some features inside the cells. The morphological features of apoptosis consist of chromatin condensation, nuclear fragmentation, an increase cell density and the formation of cytoplasmic blebs. The nucleus acquires an irregular shape, nucleolar size increases and its granules become enlarged and spread out \[[@bib46]\]. The final stage of apoptosis is characterized by DNA degradation and cell damage into dense membrane-surrounded fragments (apoptotic bodies). Some apoptotic bodies contain fragments of the nucleus, while others contain only cytoplasm \[[@bib47]\]. Therefore, nuclear condensation can be used to determined apoptotic cells from healthy cells or necrotic cells. Dyes that bind to DNA, such as Hoechst 33342, can be used to observe nuclear condensation ([Fig. 6](#fig6){ref-type="fig"}). Cells that have died by apoptosis will generally display condensed DNA and fragmented nuclei, meanwhile the healthy and necrotic cells do not \[[@bib48]\]. Dual AO/EB fluorescent staining also detect basic morphological changes in apoptotic cells and necrotic cells on A549 treated with EEOS ([Fig. 6](#fig6){ref-type="fig"}). Liu et al. 2015 proposed that AO penetrated normal and early apoptotic cells with intact membranes, fluorescing green when bound to DNA. EB only entered cells with damages membranes, such as late apoptotic and dead cells, emitting orange-red fluorescence when bound to concentrated DNA fragments or apoptotic bodies \[[@bib49]\].

To strengthen our results, we performed the antioxidant enzymes activities for SOD2 and GPx. SOD drives the reaction of dismutation of superoxide into hydrogen peroxide. The SOD2 or also known as manganese-dependent superoxide dismutase (MnSOD) is mainly localized in the mitochondria \[[@bib50], [@bib51]\] and the first detoxification enzyme. However, MnSOD overexpression is common in tumors and contribute to therapy resistance \[[@bib52]\]. From the results we can see the gradually decreasing level of SOD~2~ meanwhile on the concentration EEOS at 200 μg/mL there is slightly increasing level of SOD~2~. Since mitochondria are the major source of reactive oxygen species, decreasing their detoxifying ability by means blocking SOD~2~ activity in cancer might contribute to induce apoptosis \[[@bib50]\]. Plumbagin proved to efficiently induce apoptosis in effect in prostate cancer cell lines, partially through decreasing SOD~2~ expression \[[@bib53]\]. Phenethyl isothiocyanate was found to inhibit expression of SOD~2~ in LN229 glioma cell line, weakening cellular antioxidant defense and causing apoptosis \[[@bib54]\]. Suppression of SOD~2~ enzymatic activity by apigenin in combination with ROS-inducing paclitaxel was found to sensitize HeLa cells to apoptosis and allowed to lower paclitaxel doses \[[@bib55]\]. Apigenin is one of chemical constituent which presents in *Ocimum sanctum* extract. It had been reported that apigenin could form stabel complexation with metal ions in vitro \[[@bib56]\] and decrease SOD activity by blocking SOD from assemble with its cofactors. It has been addressed that apigenin was a potential inducer of intracellular oxidative stress \[[@bib57]\].

In addition, we perform an ELISA assay for glutathione peroxidase (GPx). The GPx is a enzymatic scavenger of proxides (H~2~O~2)~, thus H~2~O~2~ can be detoxified by GPx and converted into H~2~O \[[@bib58], [@bib59]\]. The clinical importance of GPx has been underlined by a number of studies. Increasing level of GPx can protect the cells against hydrogen peroxide induce cell death or apoptotic, meanwhile depletion or silencing GPx may suppresses cell cancer growth \[[@bib60]\]. In addition, lower GPx activity is predisposed to impaired antioxidant protection, which leads to oxidative damage to the cancer cells \[[@bib61]\]. Forgione and colleagues \[[@bib62]\] had previously hypothesized that GP~X~ deficiency directly induces an increase in vascular oxidative stress, with attendant endothelial dysfunction. Based on our GPx experimental results, we observe gradual decrement of GPx-activity during the treatment of cancer cells with increased EEOS concentration (from 50 ug/ml to 100 ug/ml). These results indicated that specific EEOS concentration presumably induced the increases of the lipid peroxidation, which therefore prevent it\'s enzymatic activity, and prevent the cytoprotective effect of cancer cells. Interestingly, the GPx-activity-inhibition effect was abolished by the treatment of high dose EEOS (200 ug/ml), To answer the phenomenon that the EEOS at 200 ug/ml is always less effective than lower concentrations, we did an experiment by Thin Layer Chomatography (TLC) to analyse the ingredient of the EEOS. Based on the TLC results the EEOS contain abundant polyphenol (12.50 % b/b) and flavonoid (28.22%b/b) on the EEOS ([Fig. 7](#fig7){ref-type="fig"}). Our data is in line with the other research before, which is mention the EEOS contained many substances consisting of apigenin, luteolin, apigenin-7-O-β-D-rutinopyranoside, luteolin-7-O- β-D-glucopyranoside, vicenin-2, vitexin, isovitexin, orientin, isoorientin, aesculetin, aesculin, chlorogenic acid, eugenol, and caffeic acid \[[@bib63], [@bib64], [@bib65]\]. Phenol and flavonoids have gained importance as anti-cancer agents and have shown great potential as cytotoxic anti-cancer agents promoting apoptosis in cancer cells \[[@bib66]\]. Danciu et al. \[[@bib67]\] reported the increase in anticancer activity was correlated with the increase in amount of polyphenol compounds. Moreover, the results from many biomedical research teams indicated that various kinds of flavonoids can promote apoptosis in various cancer cells \[[@bib68], [@bib69], [@bib70]\]. Presumably, some substances such as eugenol induced general protective effects \[[@bib64], [@bib71], [@bib72]\], and in contrary, some substance such as flavonoid and phenol is well known as specific cancer cells inhibiting agents, both in different opposite effective dose dependent functionality, and could causes different physiological mechanism within different doses. It is likely that this reason causes EEOS to be less effective at a concentration of 200 ug/ml due to the work imbalance of the active substance. Thus it is important to separate the active substance from EEOS to be able to optimize the cytotoxicity function of EEOS.

In conclusion, the present study demonstrates the significant evidence of EEOS treatment in altering the viability of lung adenocarcinoma A549 cells through a synergy of induction of apoptotic signaling via intrinsic-mitochondria pathway. Further research is needed to isolate the phytochemicals that are responsible for cancer cell apoptosis.

5. Conclusion {#sec5}
=============

Taking together, our results showed that EEOS provide anticancer activity by decreasing cell proliferation and viability, increasing intracellular ROS, interfere the activity of SOD and GPx thus promoting apoptosis in A549 cells. The results derived from our investigation confirmed the therapeutic potency of EEOS.
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